Edwards Lifesciences (EW) Profit Margin History

Historical gross, operating and net quarterly profit margin for Edwards Lifesciences (EW) over the last 10 years. The current net profit margin for Edwards Lifesciences as of June 22, 2018 is 17.36%.

Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $32.076B $3.435B
Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.